Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries

Volumetric neuroimaging and traumatic brain injuries

Of the 1.5 million traumatic brain injuries (TBI) every year, 80% of them are considered mild. A “mild TBI”, often referred to as a concussion, is defined as loss of consciousness and/or confusion and disorientation, which is shorter than 30 minutes and an initial Glasgow Coma Scale (GCS) of 13-15.

A patient a with mild TBI does not initially present with any visible pathology, such as fractures, contusions, and hemorrhages. Long-term, however, the patient may possess disabling cognitive, psychological, and/or behavioral impairments and employment disabilities. In fact, recent studies have demonstrated that neurologic and psychiatric problems persist in 10-50% of brain trauma patients and maybe severe enough that cognitive defects never return to a pre-injury state.

Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries
Graph displaying increased risk of neurodegeneration with a brain injury. Image source: Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

Any injury to the brain can generate significant loss of brain volume, which in turn can initiate neuropathological changes, such as the presence of certain biomarkers (β-amyloid and tau), as well as neuroinflammatory changes. These changes can cause a younger aged brain to have symptoms that resemble an older neurodegenerative brain.

Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries
T1-weighted coronal images displaying hippocampal atrophy, ventricular dilation and sulcal widening in both an 86 year old patient clinically diagnosed with Alzheimer’s disease and a 14 year old patient with severe TBI, as compared to a healthy 14 year old. Image source: Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

Using MRI scans and sophisticated software tools for quantitative imaging (NeuroQuant) to analyze the resulting images has become a significant element in the assessment of patients with TBI. Volumetric MRI studies performed after a brain injury can provide physicians with regional and whole brain volumes, which can be followed over time. This is especially meaningful, as global and regional brain atrophy from a single minor brain injury or concussion, can be detected one year after the injury.

NeuroQuant is a leading medical device software that automatically and accurately segments and calculates brain structure volumes from the 3D MR images, thereby providing anatomic information about the brain in a non-invasive fashion.

For physicians evaluating TBI, the Triage Brain Atrophy report provides volume measurements of 39 left and right brain structures and indicates the patient’s brain structure volume measurements as compared to a healthy population (Cortechs.ai’ normative reference data). This information provides physicians with an accurate indication of where an individual’s brain structure volumes are compared with their age- and gender-matched peers. The Triage Brain Atrophy report provides critical supporting quantitative volumetric data to aid physicians in their assessment of TBI.


References:

[1]        Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

[2]        Zhou, Y., Kierans, A., et al. (2013). Mild traumatic brain injury: longitudinal regional brain volume changes. Radiology: (3) 267:880-890.

More Resources

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.

05/26/2026

ASNR 2026 Highlights the Growing Role of Quantitative Imaging in Neurology

ASNR 2026 brought together leaders across neuroradiology, imaging AI, and neurological care to explore the future of quantitative imaging.

05/11/2026

Better Models, Better Care: Inside Our Latest Brain Tumor Update

Explore how NeuroQuant® Brain Tumor v2.1 advances AI-powered brain tumor segmentation and clinical workflows.

05/05/2026

The American Academy of Neurology: Shaping the Future of Neurologic Care 

AI-driven clinical quantification is becoming standard in neurologic care

04/27/2026

Deep Learning Reconstruction and Quantitative MRI: Advancing Imaging Without Compromising Consistency

Deep learning reconstruction enhances MRI speed and clarity while preserving the consistency and reliability of quantitative imaging
Scroll to Top